Literature DB >> 7581783

[Chronic septic granulomatosis revealed by neonatal pulmonary aspergillosis].

R Mouy1, J C Ropert, J Donadieu, P Hubert, J de Blic, Y Revillon, F Brunelle, S Schollet Martin, B Descamps, M Debré.   

Abstract

BACKGROUND: Pulmonary aspergillosis is now the main cause of death in chronic granulomatous disease (CGD); it may occur before the age of one year and then often reveals CGD. CASE REPORT: A male newborn was referred to hospital at 27 days of age for fever (39 degrees C), hemodynamic failure and biological inflammation syndrome caused by pulmonary infection. Chest CT scan revealed multiple and bilateral intraparenchymatous nodules. An open lung biopsy showed histiocystic granuloma with multinucleated giant cells. Culture of tracheal, bronchoalveolar lavage samples and lung biopsy grew positive for Aspergillus fumigatus. Impaired chemiluminescence production by neutrophils was detected, enabling the diagnosis of CGD. It was later confirmed by the study of neutrophils functions. The child recovered after 12 months of parenteral amphotericin B therapy.
CONCLUSION: A febrile multifocal pneumopathy occurring in infancy should lead to consider the possibility of CGD which may be confirmed by the chemiluminescence test.

Entities:  

Mesh:

Year:  1995        PMID: 7581783     DOI: 10.1016/0929-693x(96)81264-4

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn.

Authors:  Milica Miladinovic; Boris Wittekindt; Sebastian Fischer; Elise Gradhand; Steffen Kunzmann; Stefanie Y Zimmermann; Shahrzad Bakhtiar; Thomas Klingebiel; Rolf Schlösser; Thomas Lehrnbecher
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

2.  Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease.

Authors:  Roxane Labrosse; Jane Abou-Diab; Annaliesse Blincoe; Guilhem Cros; Thuy Mai Luu; Colette Deslandres; Martha Dirks; Laura Fazilleau; Philippe Ovetchkine; Pierre Teira; Françoise LeDeist; Isabel Fernandez; Fabien Touzot; Helene Decaluwe; Ugur Halac; Elie Haddad
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.